Pharmaceuticals News

BJD leader Bhartruhari Mahtab seeks probe into efficacy of generic drugs

BJD member Bhartruhari Mahtab cited a recent book, which, according to him, claimed that Indian domestic drug manufacturers were not producing quality generic drugs.

Nagpur-based pharma exporter nabbed in Prague by US drug authorities

Many medicine exporters make big money out of export business since in countries like US, medical treatment is costly and hence there are a lot of buyers of cheap medicines coming from countries like India.


Panel to firms: Prove that 324 combination drugs are safe to use

The medicines, known as fixed dose combinations, were declared ‘irrational’ by a Health Ministry panel set up in 2014.

New 'chemputer' system may revolutionise drug production

While recent advances in chemical production have allowed some chemical compounds to be produced at laboratory scale via automated systems, the chemputer is underpinned by a new universal and interoperable standard for writing and sharing chemical recipes.

Drop in supplies: Price of key drug for kids with heart ailment hiked

The ceiling price will be raised to Rs 2.60 per ml against the current 29 p per ml — the price of a 30 ml bottle will go up from Rs 10 to Rs 78.

Who is Martin Shkreli 'the most hated man in America'?

Martin Shkreli came to be known as "Pharma Bro" at time after founding Turing Pharmaceuticals, buying the anti-parasitic drug Daraprim and raising its price by 5,000 percent to $750 per pill.


'Pharma Bro' Martin Shkreli sentenced to seven years for defrauding investors

The Brooklyn-born entrepreneur became known as the "Pharma Bro" in September 2015 after founding Turing Pharmaceuticals, buying the anti-parasitic drug Daraprim and raising its price by 5,000 percent to $750 per pill.

Eco-friendly method can turn raw biomass into high value chemicals, pharmaceuticals

An international team of researchers, including from India and Bangladesh, has developed a cost-effective method of converting non-edible agricultural biomass, such as jute, or the waste by-product from food crops, into commercially valuable chemicals for food and pharmaceutical companies. Researchers from the University of Wollongong (UOW), working with colleagues in India, Bangladesh and Taiwan who […]

Easing licence extension for drug makers, sellers

The Central Drugs Standard Control Organisation has proposed charging a licence retention fee from drug manufacturers and chemists instead of the current renewal process; the fee for medical devices is expected to be in the range of `100-50,000.

India to unveil new drug policy: Officials

Over the last few years, clinical trials in India slowed down amid tedious court litigation and rising protests from health activists on issues related to informed consent and compensation norms, an official statement said.